We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00736216
Recruitment Status : Withdrawn (PI left the institution)
First Posted : August 15, 2008
Last Update Posted : March 19, 2015
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

Brief Summary:

RATIONALE: Learning about young adults' knowledge and perceptions about risk factors for the human papilloma virus and cervical cancer may help doctors learn more about how to prevent human papilloma virus infection and cervical cancer in the future.

PURPOSE: This clinical trial is studying knowledge and perceptions of the risk factors for human papilloma virus infection and cervical cancer in young adults.


Condition or disease Intervention/treatment Phase
Cervical Cancer Precancerous Condition Other: survey administration Phase 1

Detailed Description:

OBJECTIVES:

  • Describe the socio-demographic context of college students in an urban Midwestern setting.
  • Assess knowledge of the human papillomavirus (HPV) and cervical cancer in these participants.
  • Assess the population's perception of HPV risk.
  • Assess the prevalence of risk behaviors that may place this population at risk for HPV.
  • Identify the best predictors of HPV knowledge and cervical cancer knowledge.
  • Assess vaccine knowledge and acceptance in these participants.

OUTLINE: Participants complete the Young Adult Survey online documenting demographic data; sexual history (i.e., whether they ever had sex, age of first sexual encounter, number of life time partners, condom use, sexually transmitted diseases [STDs], and pregnancy history); cigarette use; current and past drug use; knowledge of human papillomavirus (HPV) and cervical cancer; past history of Pap tests and STD screenings; attitudes towards HPV testing; vaccine knowledge and acceptability; sources of information about HPV; source of information about cervical cancer; identification of common STDs; perceived risk of acquiring STDs; perceived risk of acquiring HPV; social support; and religion.


Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Knowledge and Perceptions About Human Papillomavirus and Cervical Cancer Risk Among Young Adults
Study Start Date : July 2008
Primary Completion Date : July 2009

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cervical Cancer
U.S. FDA Resources


Intervention Details:
    Other: survey administration
    Participants complete the Young Adult Survey online documenting demographic data; sexual history (i.e., whether they ever had sex, age of first sexual encounter, number of life time partners, condom use, sexually transmitted diseases [STDs], and pregnancy history); cigarette use; current and past drug use; knowledge of human papillomavirus (HPV) and cervical cancer; past history of Pap tests and STD screenings; attitudes towards HPV testing; vaccine knowledge and acceptability; sources of information about HPV; source of information about cervical cancer; identification of common STDs; perceived risk of acquiring STDs; perceived risk of acquiring HPV; social support; and religion.


Primary Outcome Measures :
  1. Socio-demographic context of college students in an urban Midwestern setting
  2. Knowledge of human papillomavirus (HPV) and cervical cancer
  3. Perception of HPV risk
  4. Prevalence of risk behaviors that may place this population at risk for HPV
  5. Best predictors of HPV knowledge and cervical cancer knowledge
  6. Vaccine knowledge and acceptance


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 24 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Community based outreach in an urban Mid-west area
Criteria

DISEASE CHARACTERISTICS:

  • Currently enrolled in a college, university, or community college in the Greater Cleveland metropolitan area
  • Currently single and never married

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00736216


Locations
United States, Ohio
Geauga Regional Hospital
Cleveland, Ohio, United States, 44024
Lake/University Ireland Cancer Center
Cleveland, Ohio, United States, 44060
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106-5065
University Suburban Health Center
Cleveland, Ohio, United States, 44121
UHHS Chagrin Highlands Medical Center
Cleveland, Ohio, United States, 44122
Southwest General Health Center
Cleveland, Ohio, United States, 44130
UHHS Westlake Medical Center
Cleveland, Ohio, United States, 44145
Mercy Cancer Center at Mercy Medical Center
Cleveland, Ohio, United States, 44708
Sponsors and Collaborators
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Investigators
Principal Investigator: Shelley A. Francis, PhD, MPH, CHES Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Responsible Party: Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier: NCT00736216     History of Changes
Other Study ID Numbers: CASE11806
P30CA043703 ( U.S. NIH Grant/Contract )
CASE11806 ( Other Identifier: Case Comprehensive Cancer Center )
CASE-11806-CC231
First Posted: August 15, 2008    Key Record Dates
Last Update Posted: March 19, 2015
Last Verified: March 2015

Keywords provided by Case Comprehensive Cancer Center:
cervical cancer
human papilloma virus infection

Additional relevant MeSH terms:
Uterine Cervical Neoplasms
Precancerous Conditions
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases
Genital Diseases, Female